These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 7774657

  • 1. Antinociceptive effect of dihydroetorphine in diabetic mice.
    Kamei J, Suzuki T, Misawa M, Nagase H, Kasuya Y.
    Eur J Pharmacol; 1995 Feb 24; 275(1):109-13. PubMed ID: 7774657
    [Abstract] [Full Text] [Related]

  • 2. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
    Kamei J, Zushida K, Ohsawa M, Nagase H.
    Eur J Pharmacol; 2000 Mar 10; 391(1-2):91-6. PubMed ID: 10720639
    [Abstract] [Full Text] [Related]

  • 3. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
    Kamei J, Iwamoto Y, Hitosugi H, Misawa M, Nagase H, Kasuya Y.
    Neurosci Lett; 1994 Jan 03; 165(1-2):141-3. PubMed ID: 8015716
    [Abstract] [Full Text] [Related]

  • 4. Antitussive effect of dihydroetorphine in mice.
    Kamei J, Iwamoto Y, Suzuki T, Misawa M, Nagase H, Kasuya Y.
    Eur J Pharmacol; 1994 Aug 01; 260(2-3):257-9. PubMed ID: 7988653
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
    Nozaki C, Saitoh A, Kamei J.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):145-51. PubMed ID: 16533506
    [Abstract] [Full Text] [Related]

  • 6. Agonist and antagonist properties of dihydroetorphine for mu-opioid receptors in mice.
    Kamei J, Suzuki T, Nagase H.
    Neurosci Lett; 1996 Sep 06; 215(2):87-90. PubMed ID: 8888002
    [Abstract] [Full Text] [Related]

  • 7. Effect of diabetes on pinacidil-induced antinociception in mice.
    Zushida K, Onodera K, Kamei J.
    Eur J Pharmacol; 2002 Oct 25; 453(2-3):209-15. PubMed ID: 12398906
    [Abstract] [Full Text] [Related]

  • 8. Dihydroetorphine is a mu-receptor-selective ligand.
    Wang DX, Lu XQ, Qin BY.
    J Pharm Pharmacol; 1995 Aug 25; 47(8):669-73. PubMed ID: 8583370
    [Abstract] [Full Text] [Related]

  • 9. The effect of chronic treatment with naltrindole, a selective delta-opioid antagonist, on mu-opioid receptor-mediated antinociception in diabetic mice.
    Kamei J, Kawashima N, Iwamoto Y, Suzuki T, Nagase H, Misawa M, Kasuya Y.
    Psychopharmacology (Berl); 1993 Aug 25; 113(2):167-71. PubMed ID: 7855177
    [Abstract] [Full Text] [Related]

  • 10. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL, Bartlett JL, Ananthan S, Bilsky EJ.
    J Pharmacol Exp Ther; 2001 May 25; 297(2):597-605. PubMed ID: 11303048
    [Abstract] [Full Text] [Related]

  • 11. Antinociceptive effect of oxycodone in diabetic mice.
    Nozaki C, Saitoh A, Tamura N, Kamei J.
    Eur J Pharmacol; 2005 Nov 07; 524(1-3):75-9. PubMed ID: 16256106
    [Abstract] [Full Text] [Related]

  • 12. Involvement of mu1-opioid receptor on oxycodone-induced antinociception in diabetic mice.
    Nozaki C, Kamei J.
    Eur J Pharmacol; 2007 Apr 10; 560(2-3):160-2. PubMed ID: 17292346
    [Abstract] [Full Text] [Related]

  • 13. Involvement of delta 1-opioid receptors in the antinociceptive effects of mexiletine in mice.
    Kamei J, Saitoh A, Kasuya Y.
    Neurosci Lett; 1995 Aug 25; 196(3):169-72. PubMed ID: 7501275
    [Abstract] [Full Text] [Related]

  • 14. Antinociceptive effect of L-arginine in diabetic mice.
    Kamei J, Iwamoto Y, Misawa M, Nagase H, Kasuya Y.
    Eur J Pharmacol; 1994 Mar 11; 254(1-2):113-7. PubMed ID: 8206107
    [Abstract] [Full Text] [Related]

  • 15. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
    Sakurada S, Takeda S, Sato T, Hayashi T, Yuki M, Kutsuwa M, Tan-No K, Sakurada C, Kisara K, Sakurada T.
    Eur J Pharmacol; 2000 Apr 28; 395(2):107-12. PubMed ID: 10794815
    [Abstract] [Full Text] [Related]

  • 16. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
    Bedini A, Baiula M, Gentilucci L, Tolomelli A, De Marco R, Spampinato S.
    Peptides; 2010 Nov 28; 31(11):2135-40. PubMed ID: 20713109
    [Abstract] [Full Text] [Related]

  • 17. Antinociceptive effect of lipopolysaccharide from Pantoea agglomerans on streptozotocin-induced diabetic mice.
    Kamei J, Iwamoto Y, Suzuki T, Misawa M, Kasuya Y, Nagase H, Okutomi T, Soma G, Mizuno D.
    Eur J Pharmacol; 1994 Jan 04; 251(1):95-8. PubMed ID: 8137875
    [Abstract] [Full Text] [Related]

  • 18. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
    Yang PP, Yeh GC, Yeh TK, Xi J, Loh HH, Law PY, Tao PL.
    Pharmacol Res; 2016 Sep 04; 111():867-876. PubMed ID: 27496654
    [Abstract] [Full Text] [Related]

  • 19. Effect of diabetes on the antinociceptive effect of beta-endorphin.
    Kamei J, Kawashima N, Hitosugi H, Misawa M, Nagase H, Kasuya Y.
    Brain Res; 1993 Aug 13; 619(1-2):76-80. PubMed ID: 8374794
    [Abstract] [Full Text] [Related]

  • 20. Effects of diabetes on the antinociceptive effect of (+/-)pentazocine in mice.
    Kamei J, Iwamoto Y, Misawa M, Nagase H, Kasuya Y.
    Res Commun Chem Pathol Pharmacol; 1994 Apr 13; 84(1):105-10. PubMed ID: 8042002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.